Physician profile
Alessi Rispoli
NPI 1164568531
$1,298.23
in general payments reported to CMS, 2019-2025
11 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $544 · 2021: $48.78 · 2022: $93.66 · 2023: $73.99 · 2024: $182 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $606.40 | 2019-2024 | Misight Contact Lens |
| Alcon Vision LLC | $280.57 | 2021-2025 | Precision7, Total30, Eysuvis |
| Aerie Pharmaceuticals, INC. | $125.00 | 2019 | |
| Abbvie INC. | $61.77 | 2022 | |
| Bausch & Lomb Americas INC. | $51.96 | 2023-2024 | Infuse |
| Allergan, INC. | $48.94 | 2021-2022 | |
| Biotissue Holdings INC. | $35.65 | 2023-2024 | |
| Abb Con-Cise Optical Group LLC | $26.25 | 2025 | Spectacle Lenses |
| Tarsus Pharmaceuticals, INC. | $24.47 | 2024 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alessi Rispoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.